KR930023357A - Conjugates of tocopherol-salicylic acid derivatives and preparation method thereof - Google Patents

Conjugates of tocopherol-salicylic acid derivatives and preparation method thereof Download PDF

Info

Publication number
KR930023357A
KR930023357A KR1019920007662A KR920007662A KR930023357A KR 930023357 A KR930023357 A KR 930023357A KR 1019920007662 A KR1019920007662 A KR 1019920007662A KR 920007662 A KR920007662 A KR 920007662A KR 930023357 A KR930023357 A KR 930023357A
Authority
KR
South Korea
Prior art keywords
tocopherol
salicylic acid
hydrogen
general formula
acid derivative
Prior art date
Application number
KR1019920007662A
Other languages
Korean (ko)
Inventor
서대언
양현옥
김용철
강영화
Original Assignee
한병훈
Filing date
Publication date
Application filed by 한병훈 filed Critical 한병훈
Publication of KR930023357A publication Critical patent/KR930023357A/en

Links

Abstract

본 발명은 다음 일반식(Ⅰ)의 토코페롤- 살리실산 유도체의 콘주게이트 화합물을 제공하는 것이며,The present invention provides a conjugated compound of the following tocopherol-salicylic acid derivative of general formula (I),

식중 R은 수소, 탄산수 1-4의 저급알킬, 탄소수 1-4의 저급알카노일이며, R1, R2및 R3는 각각 수소원자 또는 메틸기이다.(단, R1, R2및 R3는 동시에 수소원자는 아니다.)Wherein R is hydrogen, lower alkyl of 1-4 carbon atoms, lower alkanoyl of 1-4 carbon atoms, and R 1 , R 2 and R 3 are each a hydrogen atom or a methyl group, provided that R 1 , R 2 and R 3 Is not a hydrogen atom at the same time.)

상기 일반식(Ⅰ)의 토코페롤-살리실산 유도체의 콘주게이트 화합물은 우수한 향산화효과 및 말초순화게선 효과를 가지고 있으나 궤양형성효과는 낮은 우수한 약리효과를 가진다.The conjugate compound of the tocopherol-salicylic acid derivative of the general formula (I) has excellent antioxidative effect and peripheral purge effect, but ulceration effect has low excellent pharmacological effect.

Description

토코페롤-살리실산 유도체의 콘주게이트 및 그 제조방법.Conjugates of tocopherol-salicylic acid derivatives and methods for their preparation.

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

제 1도는 토코페롤- 아스피린 콘주게이트의 NMR 챠트이며, 제 2도는 토코페롤- 살리실산 콘주게이트의 NMR챠트이다.FIG. 1 is an NMR chart of the tocopherol-aspirin conjugate, and FIG. 2 is an NMR chart of the tocopherol-salicylic acid conjugate.

Claims (2)

다음 일반식(Ⅰ)로 표시되는 토코페롤- 살리실산 유도체의 콘주게이트 화합물.The conjugate compound of the tocopherol-salicylic acid derivative represented by following General formula (I). 식중, R은 수소, 탄소수 1-4의 저급알킬, 탄소수 1-4의 저급알카노일이며, R1, R2및 R3는 각각 수소원자 또는 메틸기이다.(단, R1, R2및 R3는 동시에 수소원자는 아니다)Wherein R is hydrogen, lower alkyl having 1-4 carbons, lower alkanoyl having 1-4 carbons, and R 1 , R 2 and R 3 are each hydrogen or methyl, provided that R 1 , R 2 and R 3 is not a hydrogen atom at the same time) 다음 일반식(Ⅱ)의 살리실산 유도체를 다음 일반식(Ⅲ)의 토코페롤 유도체와 반응시켜서 다음 일반식(Ⅰ)의 토코페롤-살리실산 유도체의 콘주게이트 화합물을 제조하는 방법.A method for preparing a conjugate compound of tocopherol-salicylic acid derivative of the following general formula (I) by reacting a salicylic acid derivative of the following general formula (II) with a tocopherol derivative of the following general formula (III). 식중, R은 수소, 탄소수 1-4의 저급알킬, 탄소수 1-4의 저급알카노일이며, R1,R2및 R3는 각각 수소원자 또는 메틸기이며( 단, R1, R2및 R3는 동시에 수소원자는 아니다.) M은 수소원자 또는 알칼리금속원자이며, W는 이탈기이다.Wherein R is hydrogen, lower alkyl having 1-4 carbons, lower alkanoyl having 1-4 carbons, and R 1 , R 2 and R 3 are each hydrogen or methyl groups, provided that R 1 , R 2 and R 3 Is not a hydrogen atom.) M is a hydrogen atom or an alkali metal atom, and W is a leaving group. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019920007662A 1992-05-06 Conjugates of tocopherol-salicylic acid derivatives and preparation method thereof KR930023357A (en)

Publications (1)

Publication Number Publication Date
KR930023357A true KR930023357A (en) 1993-12-18

Family

ID=

Similar Documents

Publication Publication Date Title
KR840009092A (en) Method for preparing benzofuran- or benzopyran-carboxamide derivatives
KR930702254A (en) Anilide Derivatives
SE8003815L (en) Alkyl KETOHEXOPYRANOSID DERIVATIVES
KR910019977A (en) Carbazole compounds
KR900004820A (en) Stabilized Synthetic Resin Composition
ES548357A0 (en) PROCEDURE FOR PREPARING DERIVATIVES OF N- (ADAMANTIL-1) -PIRROLIDON-5-CARBOXAMIDA-2.
KR890014523A (en) Pyrimidine derivatives, preparation method thereof and herbicidal composition containing the same
KR900016178A (en) 2-substituted N, N'-ditrimethoxybenzoyl piperazine, preparation method thereof and therapeutic composition containing the same
KR870003107A (en) Method for preparing chianthine derivative
KR960700245A (en) Methotrexate derivative [METHOTREXATE DERIVATIVE]
KR930023357A (en) Conjugates of tocopherol-salicylic acid derivatives and preparation method thereof
KR860002517A (en) Method for preparing tris (β, β-dimethylphenethyl) tin compound
KR920702685A (en) 4,6-O-hydroxyphosphorylglucosamine derivative
KR930007880A (en) Bis (phenyl) ethane derivatives
KR950018171A (en) Vulcanizable Epichlorohydrin Polymer Composition
KR920008012A (en) Triazole derivatives
KR860008184A (en) Preparation of Dioxolobenzoisoxazole Derivatives
DE69015220D1 (en) Glycocyamidine derivatives.
KR840004105A (en) Process for preparing N, N-substituted azole carboxamide derivatives
KR900016184A (en) 1,3-dioxane derivative
KR870007907A (en) Preparation of diene derivative
KR930004294A (en) Process for preparing quinolone derivative
KR970027043A (en) Novel anthraquinone derivatives and preparation methods thereof
KR940002256A (en) Cefem derivatives
KR960041185A (en) Amine Compound Containing Organosilicon Group